Table 2. Predictors of death: Final models.

Variable	HR (95%CI)	p
WHOLE COHORT (n = 242)
Week-2-MP	0.35 (0.11–1.06)	0.064
Non-pulse glucocorticoids	3.01 (1.28–7.14)	0.012
Hypertension	2.89 (0.91–9.17)	0.072
SpO2/FiO2	0.94 (0.91–0.98)	0.001
CURB65
Low risk	Reference
Intermediate risk	1.64 (0.55–4.88)	0.371
High risk	7.72 (2.56–23.26)	<0.001
PATIENTS WITH SpO2/FiO2 ≤353 (n = 122)
Week-2-MP	0.31 (0.08–1.12)	0.073
Non-pulse glucocorticoids	2.98 (1.09–8.17)	0.034
Hypertension	3.14 (0.84–11.75)	0.089
SpO2/FiO2	0.92 (0.87-0-97)	0.002
CURB65
Low risk	Reference
Intermediate risk	1.48 (0.41–5.34)	0.546
High risk	10.29 (2.72–38.94)	0.001

Week-2-MP: methyl-prednisolone pulses in week 2. HR: hazard ratio; CI: confidence interval.

*HR for SpO2/FiO2 is change in hazard for each increase of 10 units in its value.